The sensitivity and positive predictive value (PPV) of 131I-post-therapy whole body scan is higher than serum Tg values in detecting metastases in early stage of differentiated thyroid cancer patients

被引:0
|
作者
Campenni', A. [1 ]
Pignata, S. [1 ]
Mure', M. [1 ]
Di Mauro, F. [1 ]
Stipo, M. [1 ]
Siracusa, M. [1 ]
Ruggeri, R. [2 ]
Baldari, S. [1 ]
机构
[1] Unit Nucl Med Messina, Messina, Italy
[2] Unit Endocrinol Messina, Messina, Italy
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
OP536
引用
收藏
页码:S160 / S161
页数:2
相关论文
共 50 条
  • [31] Incidence and implications of negative serum thyroglobulin but positive I-131 whole-body scans in patients with well-differentiated thyroid cancer prepared with rhTSH or thyroid hormone withdrawal
    Cherk, Martin H.
    Francis, Peter
    Topliss, Duncan J.
    Bailey, Michael
    Kalff, Victor
    CLINICAL ENDOCRINOLOGY, 2012, 76 (05) : 734 - 740
  • [32] Value of 18F-FDG Hybrid PET/MR in Differentiated Thyroid Cancer Patients with Negative 131I Whole-Body Scan and Elevated Thyroglobulin Levels
    Li, Hongyan
    Chen, Xiaomin
    Zhang, Yajing
    Wang, Kun
    Gao, Zairong
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 2869 - 2876
  • [33] Serum thyroglobulin and 131I whole body scan after recombinant human TSH stimulation in the follow-up of low-risk patients with differentiated thyroid cancer
    Torlontano, M
    Crocetti, U
    D'Aloiso, L
    Bonfitto, N
    Di Giorgio, A
    Modoni, S
    Valle, G
    Frusciante, V
    Bisceglia, M
    Filetti, S
    Schlumberger, M
    Trischitta, V
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2003, 148 (01) : 19 - 24
  • [34] Additive value of 18FDG-PET/CT to positive 131I whole body scan in recurrent differentiated thyroid cancer patients with potential influence on treatment strategy: single Egyptian center experience
    Abdelhamed, Heba M.
    Mohammed, Amira E.
    Fattahalla, Mona S.
    Askar, HebatAllah
    EGYPTIAN JOURNAL OF RADIOLOGY AND NUCLEAR MEDICINE, 2022, 53 (01):
  • [35] Additive value of 18FDG-PET/CT to positive 131I whole body scan in recurrent differentiated thyroid cancer patients with potential influence on treatment strategy: single Egyptian center experience
    Heba M. Abdelhamed
    Amira E. Mohammed
    Mona S. Fattahalla
    HebatAllah Askar
    Egyptian Journal of Radiology and Nuclear Medicine, 53
  • [36] Diagnostic 131-I Whole Body Scan in the Evaluation of Patients with Differentiated Thyroid Cancer and Serum Thyroglobulin Levels < 1 ng/mL: Seven Years of Clinical Experience.
    Lucena, I.
    Costa, L.
    Teixeira, J.
    Martins, R.
    Couto, J.
    Lopes, F.
    Duarte, H.
    Soares, O.
    Bastos, L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S449 - S449
  • [37] Evaluation of differentiated thyroid cancer (DTC) patients with negative I-131 whole body scans (WBS) and raised serum thyroglobulin (Tg) by F18-FDG PET/CT scans
    Padhy, Ajit
    Magsombol, Butch
    Ng, David
    Lam, Winnele
    Loke, Kelvin
    Kok, Tian Yue
    Tan, Andrew
    Zaheer, Sumbul
    Goh, Anthony
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [38] Serum miRNAs measurements and diagnostic radioiodine whole body scintigraphy can be useful diagnostic tool in early identifying of persistent disease in differentiated thyroid cancer (DTC) patients with uninformative Tg values
    Campenni, A.
    Aguennouz, M.
    Vento, A.
    Polito, F.
    Comis, A. D.
    Di Giorgio, R. M.
    Panasiti, F.
    Ruggeri, R. M.
    Baldari, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S74 - S74
  • [39] Clinical outcomes of negative serum thyroglobulin but positive diagnostic I-131 whole-body scans in patients with well-differentiated thyroid cancer after first remnant ablation
    Hu, Shuang
    Kuang, Anren
    Ji, Ting
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [40] 18F-FDG-PET/CT in Patients Affected by Differentiated Thyroid Carcinoma with Positive Thyroglobulin Level and Negative I-131 Whole Body Scan. It's Value Confirmed by a Bicentric Experience
    Bertagna, Francesco
    Albano, Domenico
    Bosio, Giovanni
    Piccardo, Arnoldo
    Dib, Bassam
    Giubbini, Raffaele
    CURRENT RADIOPHARMACEUTICALS, 2016, 9 (03) : 228 - 234